Target Name: BDNF
NCBI ID: G627
Review Report on BDNF Target / Biomarker Content of Review Report on BDNF Target / Biomarker
BDNF
Other Name(s): Brain derived neurotrophic factor, transcript variant 9 | BULN2 | Brain-derived neurotrophic factor (isoform a) | BDNF variant 1 | BDNF2A | Brain derived neurotrophic factor, transcript variant 8 | BDNF6B | Brain derived neurotrophic factor, transcript variant 3 | Brain derived neurotrophic factor, transcript variant 7 | BDNF5 | Brain derived neurotrophic factor, transcript variant 1 | Brain derived neurotrophic factor, transcript variant 2 | BDNF variant 8 | Neurotrophin | BDNF variant 4 | IIa | BDNF variant 18 | BDNF variant 7 | MGC34632 | Brain-derived neurotrophic factor preproprotein | Brain-derived neurotrophic factor (isoform e) | brain derived neurotrophic factor | Brain derived neurotrophic factor, transcript variant 4 | ProBDNF_(HUMAN) | BDNF variant 3 | BDNF variant 2 | Brain derived neurotrophic factor, transcript variant 5 | BDNF variant 9 | Abrineurin | BDNF precursor form | ProBDNF | Brain-derived neurotrophic factor (BDNF) | VIb | Brain-derived neurotrophic factor (isoform c) | Brain derived neurotrophic factor, transcript variant 18 | BDNF variant 5 | Brain-derived neurotrophic factor (isoform b) | IX | Brain derived neurotrophic factor, transcript variant 6 | neurotrophin | BDNF_HUMAN | ANON2 | BDNF variant 6 | abrineurin | Brain-derived neurotrophic factor

BDNF: A Potential Drug Target for Neurological Disorders

Brain-derived neurotrophic factor (BDNF) is a protein that is expressed in various tissues throughout the brain, including the neuron axon, glial cell, and dopamine neuron. It is a potent trophic factor that can promote the survival and differentiation of neural stem cells and promote the formation of new neurons. BDNF has also been shown to play a role in the development and progression of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and chronic pain. As a result, BDNF has become a promising drug target for the treatment of these disorders.

The full-length BDNF gene has four exons, each of which encodes a different splice variant. Transcript variant 9 (T-9) is the most abundant and well-studied splice variant, and it is the most widely used BDNF gene. T-9 is a highly conserved protein that is expressed in various tissues throughout the brain, including the neuron axon, glial cell, and dopamine neuron. It is a small protein that consists of 114 amino acids, and it has a calculated molecular mass of 13.9 kDa.

One of the most important functions of BDNF is its ability to promote the survival and differentiation of neural stem cells. Neural stem cells are a type of cell that have the ability to generate new neurons and neural tissues throughout the lifespan of the animal. These stem cells can differentiate into any type of neuron, including motor neurons, sensory neurons, and interneurons. By promoting the survival and differentiation of neural stem cells, BDNF can potentially be used to treat a variety of neurological disorders.

In addition to its role in promoting the survival and differentiation of neural stem cells, BDNF has also been shown to play a role in the regulation of neural network dynamics. Neural networks are a type of computational system that are used to process and transmit information in the brain. They are made up of a large number of interconnected neurons that communicate with one another through a complex network of synapses. BDNF has been shown to regulate the number of neurons that are present in the network, as well as the strength of the connections between them. This regulation is important for the proper functioning of the neural network and for the development and progression of various neurological disorders.

Another function of BDNF is its ability to modulate pain perception. Pain is a highly unpleasant sensation that is associated with tissue damage and inflammation. BDNF has been shown to play a role in the regulation of pain perception by modulating the activity of a type of receptor called GPR55. GPR55 is a G protein that is involved in the regulation of pain perception and other physiological processes. BDNF has been shown to block the activity of GPR55, which can lead to the inhibition of pain perception.

In addition to its role in promoting the survival and differentiation of neural stem cells, modulating pain perception, and regulating neural network dynamics, BDNF is also known to be involved in the development and progression of various neurological disorders. For example, BDNF has been shown to be decreased in the brains of individuals with Alzheimer's disease, a progressive neurodegenerative disorder that is characterized by the progressive loss of brain cells. This decrease in BDNF has been shown to contribute to the development and progression of Alzheimer's disease.

Despite the promising potential of BDNF as a drug target, there are also a number of challenges and obstacles that must be overcome in order to successfully develop it for use in treating neurological disorders. One of the main challenges is the difficulty of targeting BDNF, as it is expressed in various tissues throughout the brain and its levels are difficult to regulate. Additionally, the complexity of the neural network and the difficulty of modulating its activity make it difficult to predict the effects of BDNF

Protein Name: Brain Derived Neurotrophic Factor

Functions: Important signaling molecule that activates signaling cascades downstream of NTRK2 (PubMed:11152678). During development, promotes the survival and differentiation of selected neuronal populations of the peripheral and central nervous systems. Participates in axonal growth, pathfinding and in the modulation of dendritic growth and morphology. Major regulator of synaptic transmission and plasticity at adult synapses in many regions of the CNS. The versatility of BDNF is emphasized by its contribution to a range of adaptive neuronal responses including long-term potentiation (LTP), long-term depression (LTD), certain forms of short-term synaptic plasticity, as well as homeostatic regulation of intrinsic neuronal excitability

The "BDNF Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BDNF comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BDNF-AS | BDP1 | BEAN1 | BEAN1-AS1 | BECN1 | BECN2 | BEGAIN | BEND2 | BEND3 | BEND3P3 | BEND4 | BEND5 | BEND6 | BEND7 | BEST1 | BEST2 | BEST3 | BEST4 | BET1 | BET1L | beta-Adrenoceptor | beta-Crystallin | beta-Hexosaminidase Complex | beta-Secretase | BEX1 | BEX2 | BEX3 | BEX4 | BEX5 | BFAR | BFSP1 | BFSP2 | BFSP2-AS1 | BGLAP | BGLT3 | BGN | BHC complex | BHLHA15 | BHLHA9 | BHLHE22 | BHLHE22-AS1 | BHLHE23 | BHLHE40 | BHLHE40-AS1 | BHLHE41 | BHMT | BHMT2 | BICC1 | BICD1 | BICD2 | BICDL1 | BICDL2 | BICRA | BICRAL | BID | BIK | BIN1 | BIN2 | BIN3 | BIN3-IT1 | Biogenesis of lysosome-related organelles complex-1 | BIRC2 | BIRC3 | BIRC5 | BIRC6 | BIRC7 | BIRC8 | BISPR | BIVM | BIVM-ERCC5 | BLACAT1 | BLACE | BLCAP | BLID | BLK | BLM | BLMH | BLNK | BLOC-1 (biogenesis of lysosome-related organelles complex 1) | BLOC1S1 | BLOC1S1-RDH5 | BLOC1S2 | BLOC1S3 | BLOC1S4 | BLOC1S5 | BLOC1S5-TXNDC5 | BLOC1S6 | BLTP1 | BLTP2 | BLTP3A | BLTP3B | BLVRA | BLVRB | BLZF1 | BMAL1 | BMAL2 | BMAL2-AS1 | BMERB1 | BMF | BMI1